Evolved cyber threats target not only an organization’s vendors but their vendors as well, exposing the company to a plethora of risks that they may not genuinely be aware of. These risks range from operational, legal, compliance, reputational, to financial. In order to manage these risks properly, organizations should develop an all-encompassing risk management program that includes both third and fourth-party risk management. This ensures vetting of these parties, allowing efficient risk assessment management and minimization.
Wall Street’s Leaders and Laggards of 2024
2024 was a mixed year for biopharma stocks, with the iShares Biotechnology ETF and SPDR S&P Biotech ETF experiencing small decreases. Federal Reserve decisions caused